Neuroblastoma is a rare type of cancer that primarily affects children, particularly those under the age of 5. While it is extremely uncommon for adults to develop neuroblastoma, there have been a few documented cases. In adults, the tumor may present differently and often has a worse prognosis compared to pediatric cases. Overall, neuroblastoma is considered a childhood cancer, and adult occurrences are very rare.
Yes
Neuroblastoma-- Neuroblastoma is a tumor of the adrenal glands or sympathetic nervous system. Neuroblastomas can range from being relatively harmless to highly malignant.
neuroblastoma
neuroblastoma
1000
New-row-blas-toe-ma.
Neuroblastoma
The life expectancy for children with neuroblastoma varies significantly depending on several factors, including the age of diagnosis, stage of the disease, and response to treatment. Generally, the overall survival rate for neuroblastoma can range from about 40% to over 90% for lower-risk cases. However, high-risk neuroblastoma has a much lower survival rate, often around 30% to 50%. Advances in treatment continue to improve outcomes for many children diagnosed with this condition.
After completion of a course of treatment for neuroblastoma, physicians sometimes recommend that the child undergo an investigative operation. This procedure allows the treatment team to evaluate how effective treatment.
No alternative therapy has yet been reported to substitute for conventional neuroblastoma treatment. Complementary therapies--such as retinoic acid therapy--have been shown to be beneficial to patients when administered after a conventional.
Neuroblastoma is a type of cancer that begins in immature nerve cells. It often occurs in young children, typically under the age of 5. Neuroblastoma most commonly originates in the adrenal glands but can also develop in nerve tissue along the spine, chest, abdomen, or pelvis.
Neuroblastoma may be a genetic disease passed down from the parents. In 2004, a group of German researchers reported that a series of neuroblastomas demonstrated a consistent pattern of deletions and overrepresentations on chromosomes 3, 10.